Heghine Khachatryan: Regarding Coagulation Factor Dynamics During Pregnancy in Hemophilia B Carriers
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared JTH’s post on LinkedIn:
“This study provides an important and thought-provoking challenge to existing paradigms regarding coagulation factor dynamics during pregnancy in hemophilia B carriers.
The observation that antenatal FIX levels may increase—contrary to current guidance—has direct implications for risk stratification, peripartum planning, and therapeutic decision-making.
It underscores the need for individualized longitudinal monitoring rather than reliance on static baseline assumptions.
Moreover, these findings highlight a critical gap in evidence-based recommendations and reinforce the urgency of generating high-quality prospective data to inform updated clinical guidelines.
A valuable contribution toward more precise and personalized hemostatic care in women with inherited bleeding disorders.”
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Claire Kelly et al, published in JTH, adding:
“Engineering Bone Marrow in a Dish — A Bloody Business:
Preclinical Opportunities, Translational Use Cases, and a Call for Consensus
This review examines advances in bone marrow organoid development — integrating stem cell engineering, biomaterials, and microphysiologic systems — and proposes consensus benchmarks for an ideal ex vivo human bone marrow niche to overcome translational barriers in drug development and personalized medicine.”
Title: Contrary to current guidance, antenatal factor IX levels increase in female carriers of hemophilia B
Authors: Claire Kelly, Janet Cleary, Catriona Keenan, Isabelle Delachapelle, Leona Connolly, Mary Byrne, Mairead O’Donovan, Niamh M. O’Connell, James S. O’Donnell, Kevin Ryan, Michelle Lavin
Other posts featuring Heghine Khachatryan and JTH on Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?